Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Daniel Jeffrey Moore net worth and biography

Daniel Moore Biography and Net Worth

Director of LivaNova

Daniel Moore has primarily worked as a private investor over the past five years. Mr. Moore served as President and CEO and a member of the board of Cyberonics, Inc., a medical device company with core expertise in neuromodulation, from 2007 to 2015 when Cyberonics merged with Sorin S.p.A. to form the Company. Mr. Moore joined Cyberonics after 18 years with Boston Scientific where he was President of InterContinental as well as having roles in general management, sales and marketing earlier in his career. Mr. Moore has a B.A. from Harvard College and an Executive M.B.A. from Boston University.

Mr. Moore has extensive experience working with cutting edge medical device companies, including leadership of Cyberonics. He has significant experience in domestic and international general management and sales and marketing. Mr. Moore serves or has served on the boards of several medical device companies, the Epilepsy Foundation of America and other non-profits focused on epilepsy, the Medical Device Manufacturers Association and the Advisory Board of Purdue University’s Weldon School of Biomedical Engineering.

What is Daniel Jeffrey Moore's net worth?: The estimated net worth of Daniel Jeffrey Moore is at least $1.30 million as of April 1st, 2022. Mr. Moore owns 24,630 shares of LivaNova stock worth more than $1,299,479 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Moore may own. Learn More about Daniel Jeffrey Moore's net worth.
How do I contact Daniel Jeffrey Moore?: The corporate mailing address for Mr. Moore and other LivaNova executives is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. LivaNova can also be reached via phone at 442033250660 and via email at [email protected]. Learn More on Daniel Jeffrey Moore's contact information.
Has Daniel Jeffrey Moore been buying or selling shares of LivaNova?: Daniel Jeffrey Moore has not been actively trading shares of LivaNova in the last ninety days. Most recently, Daniel Jeffrey Moore sold 1,000 shares of the business's stock in a transaction on Friday, April 1st. The shares were sold at an average price of $83.42, for a transaction totalling $83,420.00. Following the completion of the sale, the director now directly owns 24,630 shares of the company's stock, valued at $2,054,634.60. Learn More on Daniel Jeffrey Moore's trading history.
Who are LivaNova's active insiders?: LivaNova's insider roster includes Marco Dolci (SVP), Damien McDonald (CEO), Daniel Moore (Director), and Alfred Novak (Director). Learn More on LivaNova's active insiders.

Daniel Jeffrey Moore Insider Trading History at LivaNova

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2022	Sell	1,000	$83.42	$83,420.00	24,630
3/2/2022	Sell	1,000	$80.00	$80,000.00
2/25/2022	Sell	1,000	$80.00	$80,000.00
1/3/2022	Sell	1,000	$85.93	$85,930.00
12/1/2021	Sell	1,000	$81.73	$81,730.00
11/3/2021	Sell	1,000	$85.25	$85,250.00
10/1/2021	Sell	1,000	$80.00	$80,000.00
9/1/2021	Sell	1,000	$82.40	$82,400.00	31,630
8/2/2021	Sell	1,000	$86.39	$86,390.00	32,630
11/22/2019	Sell	3,000	$80.00	$240,000.00	28,352
9/16/2019	Sell	1,500	$84.56	$126,840.00
8/19/2019	Sell	1,500	$80.25	$120,375.00
8/1/2019	Sell	6,000	$80.00	$480,000.00	34,352
3/15/2019	Sell	1,500	$96.63	$144,945.00
2/15/2019	Sell	1,500	$100.44	$150,660.00
1/15/2019	Sell	1,500	$90.80	$136,200.00
12/15/2018	Sell	1,000	$91.85	$91,850.00
11/15/2018	Sell	1,000	$116.68	$116,680.00
10/15/2018	Sell	1,000	$113.30	$113,300.00
9/17/2018	Sell	1,000	$123.49	$123,490.00
8/15/2018	Sell	1,000	$121.58	$121,580.00
7/16/2018	Sell	1,000	$102.19	$102,190.00
5/15/2018	Sell	1,000	$84.66	$84,660.00
4/16/2018	Sell	1,000	$86.24	$86,240.00
3/15/2018	Sell	1,000	$88.31	$88,310.00
2/15/2018	Sell	1,000	$83.32	$83,320.00
1/16/2018	Sell	1,000	$82.15	$82,150.00
12/15/2017	Sell	1,000	$80.80	$80,800.00
11/15/2017	Sell	1,000	$81.39	$81,390.00
10/16/2017	Sell	1,000	$74.58	$74,580.00
9/15/2017	Sell	1,000	$68.55	$68,550.00	57,296
8/15/2017	Sell	1,000	$60.76	$60,760.00	58,296
7/17/2017	Sell	1,000	$61.55	$61,550.00	56,437
6/15/2017	Sell	1,000	$60.80	$60,800.00	57,437
4/17/2017	Sell	1,000	$51.32	$51,320.00	59,437
3/15/2017	Sell	1,000	$50.21	$50,210.00	60,437
5/24/2016	Sell	1,000	$50.07	$50,070.00	64,137
4/15/2016	Sell	1,000	$54.81	$54,810.00	64,437
3/15/2016	Sell	1,000	$56.88	$56,880.00	65,437
2/16/2016	Sell	1,000	$56.88	$56,880.00	66,437
1/15/2016	Sell	1,000	$52.64	$52,640.00	67,437
12/15/2015	Sell	2,500	$53.97	$134,925.00	68,437

Daniel Jeffrey Moore Buying and Selling Activity at LivaNova

LivaNova Company Overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Today's Range

Now: $52.76

$51.71

$52.89

50 Day Range

MA: $53.55

$48.75

$57.12

2 Week Range

Now: $52.76

$42.75

$59.86

Volume

537,422 shs

Average Volume

558,805 shs

Market Capitalization

$2.85 billion

P/E Ratio

164.88

Dividend Yield

N/A

Beta

0.89